Issue 58, 2017

A bioconjugate leveraging xenoreactive antibodies to alleviate cocaine-induced behavior

Abstract

A method for potentiating the response to an anti-cocaine vaccine by leveraging xenoreactive antibodies against the carbohydrate epitope Galα1,3-Gal (GAL) was found to result in a highly specific anti-cocaine response that was able to significantly attenuate cocaine-induced locomotion at 20 mg kg−1 with superior efficacy compared to a standard conjugate.

Graphical abstract: A bioconjugate leveraging xenoreactive antibodies to alleviate cocaine-induced behavior

Supplementary files

Article information

Article type
Communication
Submitted
25 May 2017
Accepted
24 Jun 2017
First published
27 Jun 2017

Chem. Commun., 2017,53, 8156-8159

A bioconjugate leveraging xenoreactive antibodies to alleviate cocaine-induced behavior

N. T. Jacob, K. Anraku, A. Kimishima, B. Zhou, K. C. Collins, J. W. Lockner, B. A. Ellis and K. D. Janda, Chem. Commun., 2017, 53, 8156 DOI: 10.1039/C7CC04055E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements